TD Ameritrade’s (AMTD) PE ratio stood at 16.68x on a next 12-month basis, which implies discounted valuations. The average for TD Ameritrade’s competitors was 24.32x. Interactive Brokers Group (IBKR), E*TRADE Financial (ETFC), and Charles Schwab (SCHW) have PE ratios of 33.03x, 17.45x, and 22.48x, respectively, on a next 12-month basis.
Tesla stock slipped again on Tuesday, with shares now down nearly 9% since yesterday after the company announced a “more than 10%” staff reduction.
* Mexican peso weakens past 17 per dollar * Brazil's real at lowest since March 2023 * IMF sees smaller economic slowdown in Latam, Caribbean region this year * Latam FX down 1.6%, stocks fall 2.1% (Updated at 3:30pm ET/1930 GMT) By Bansari Mayur Kamdar and Lisa Pauline Mattackal April 16 (Reuters) - Latin American currencies and stocks slumped on Tuesday as the dollar soared on rising geopolitical tensions and fading hopes of a rate cut by the U.S. Federal Reserve. Mexico's peso led Latin American currencies lower with a fall of 2.0%, briefly crossing the 17 to the dollar mark and trading at a nearly two-month low.
Stocks eyed a broader comeback from a steep sell-off as investors digested results from Bank of America and other heavyweights.
Wall Street stocks ended mixed on Tuesday as Treasury yields climbed, with investors weighing the likely path of interest rates in a resilient U.S. economy with persistent inflation. Federal Reserve Chair Jerome Powell said on Tuesday recent inflation data has not given policymakers enough confidence to ease credit soon, noting that the U.S. central bank may need to keep rates higher for longer than previously thought. The Dow Jones Industrial Average got a boost from UnitedHealth Group's better-than-expected quarterly results.
Johnson & Johnson stock skidded Tuesday after light sales of blockbuster psoriasis treatment Stelara dragged the company's top line lower.
BRISBANE, Calif., April 16, 2024--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – has appointed John W. Hanna as its new President and Chief Executive Officer, and member of the Company’s Board of Directors, effective April 15, 2024.
PHOENIX, April 16, 2024--University of Phoenix celebrates the achievements and thought leadership of its more than 2,400 faculty and instructors across all seven colleges producing 1,240 instances of scholarship in 2023. Focused on the career aspirations of working adult learners, University of Phoenix operates under a practitioner model for faculty and instructors, requiring experience as practitioners in their fields of expertise to lead and teach in programs across the College of Business and
Long term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p<0.05)Significantly improved clinical outcomes associated with long-term daily oral CNM-Au8® 30 mg treatment (change from original baseline; p<0.05)Long-term CNM-Au8 treatment, encompassing up to three years, was well-tolerated; no significant safety findings were observedFirst Phase 2 clini
LONDON, April 16, 2024 (GLOBE NEWSWIRE) -- Zapp Electric Vehicles Group Limited (Nasdaq: ZAPP) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to revolutionize personal urban mobility, today announced that its shareholders approved at the Company’s annual general meeting on April 11, 2024, and that the Company will effect, a consolidation of its authorized share capital at a ratio of 1-for-20 (the “Reverse Stock Split”), in order that the share capi
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Sentia Medical Sciences Inc. today announced that they have further extended a research collaboration with Neurocrine Biosciences, Inc. (Nasdaq: NBIX) aimed at discovering novel, long-acting corticotropin-releasing factor (CRF) receptor antagonist peptide therapeutics. The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CRF biology to develop and commercialize medicine
TYSONS CORNER, Va., April 16, 2024--MicroStrategy® (Nasdaq: MSTR), the largest independent publicly-traded business intelligence company, today announced it will report its financial results for the first quarter of 2024 after the U.S. financial markets close on Monday, April 29, 2024 and will host a live Video Webinar at 5:00 p.m. Eastern Time to discuss the results.
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that on April 11, 2024, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 31,220 shares of its common stock to eight new employees, consisting of inducement stock options to purc
FORT WORTH, Texas, April 16, 2024--Omnicell Announces XT Amplify: Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System
Over 40 solid tumor patients have completed all biomarker testing in the screening protocol; ~60% of these patients qualify for at least one TCR-T in the ImmunoBank and ~30% are eligible for multiplex therapy Patients identified across all six TCR-T cohorts in solid tumor program with dosing of first three expected in early May All eight patients in the heme program treated with TSC-100 or TSC-101 remain relapse-free with no detectable cancer to date; median follow-up of >10 months WALTHAM, Mass
GREENWICH, CT., April 16, 2024--Interactive Brokers Group, Inc. (Nasdaq: IBKR), an automated global electronic broker, announced results for the quarter ended March 31, 2024.
SUNNYVALE, Calif., April 16, 2024--Alpha and Omega Semiconductor Limited ("AOS") (Nasdaq: AOSL) today announced that the company will release its financial results for the fiscal 2024 third quarter ended March 31, 2024 on Tuesday, May 7, 2024, after the market closes. The press release will be followed by a conference call and live webcast at 2:00 p.m. PT / 5:00 p.m. ET, which will be open to the public. During the conference call, the company will review the financial results and discuss other
HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 23, 2024 at 8:30 a.m. Eastern Time to report its first quarter 2024 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register
Intra-Cellular Therapies stock rocketed Tuesday after its drug, Caplyta, topped expectations in a depression treatment study.
Michelle Lennis grew up playing basketball in Indiana as a born-and-raised Purdue fan. When the Indiana Fever made Clark its No. 1 pick in the WNBA draft Monday, it immediately turned up the heat in a city and state that already live and breathe basketball. Lennis, 43, was all-in on the excitement.
In preparation for the upcoming Bitcoin halving event, BlueSky Miner introduces a special mining package designed to maximize crypto mining profitability. This new offering aims to empower both seasoned miners and novices with enhanced earning potential during this critical market phase.London, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- As the cryptocurrency community gears up for the anticipated Bitcoin halving event, BlueSky Miner, a leader in cloud mining solutions, has announced the
Yahoo Finance